45 related articles for article (PubMed ID: 1813437)
21. Pharmacokinetics and tissue distribution of ipriflavone, an isoflavone derivative, after intravenous administration to rabbits.
Kim S; Lee J; Lee M
Biopharm Drug Dispos; 2000 May; 21(4):147-56. PubMed ID: 11180193
[TBL] [Abstract][Full Text] [Related]
22. [Serum oxytetracycline concentration and its urinary excretion in patients with circulatory failure and patients with relative renal failure].
Henryk J; Kowalska M; Litwin A; Maryjewska H
Pol Tyg Lek; 1976 Sep; 31(39):1675-7. PubMed ID: 980990
[No Abstract] [Full Text] [Related]
23. Day-night variations in the renal excretion of the antiarrhythmic agent tiracizine and its metabolites.
Berndt A; Gramatté T; Oertel R; Terhaag B; Richter K; Kirch W
Chronobiol Int; 1995 Apr; 12(2):135-40. PubMed ID: 8653799
[TBL] [Abstract][Full Text] [Related]
24. Ipriflavone: A New Non-Hormonal Therapeutic Agent in Osteoporosis. Satellite symposium proceedings. Florence, Italy, April 24, 1992.
Bone Miner; 1992 Oct; 19 Suppl 1():S1-64. PubMed ID: 1358372
[No Abstract] [Full Text] [Related]
25. Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidism.
Baker JR; Peck CC; Raybuck BD; Owens EL; Schuster BG
Br J Clin Pharmacol; 1981 Mar; 11(3):305-7. PubMed ID: 7213532
[No Abstract] [Full Text] [Related]
26. Multiple peaking phenomena in pharmacokinetic disposition.
Davies NM; Takemoto JK; Brocks DR; Yáñez JA
Clin Pharmacokinet; 2010 Jun; 49(6):351-77. PubMed ID: 20481648
[TBL] [Abstract][Full Text] [Related]
27. Cross-species and interassay comparisons of phytoestrogen action.
Whitten PL; Patisaul HB
Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):5-20. PubMed ID: 11250801
[TBL] [Abstract][Full Text] [Related]
28. Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.
Adami S; Bufalino L; Cervetti R; Di Marco C; Di Munno O; Fantasia L; Isaia GC; Serni U; Vecchiet L; Passeri M
Osteoporos Int; 1997; 7(2):119-25. PubMed ID: 9166391
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone.
Giossi M; Caruso P; Civelli M; Bongrani S
Calcif Tissue Int; 1996 Jun; 58(6):419-22. PubMed ID: 8661483
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.
Cheng SL; Zhang SF; Nelson TL; Warlow PM; Civitelli R
Calcif Tissue Int; 1994 Nov; 55(5):356-62. PubMed ID: 7866917
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of nicotine in kidney failure.
Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
[TBL] [Abstract][Full Text] [Related]
32. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
33. Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.
Rondelli I; Acerbi D; Ventura P
Int J Clin Pharmacol Res; 1991; 11(4):183-92. PubMed ID: 1813437
[TBL] [Abstract][Full Text] [Related]
34. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.
Viron B; De Meyer M; Le Liboux A; Frydman A; Maillard F; Mignon F; Gaillot J
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():95-104. PubMed ID: 2387982
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of ipriflavone and metabolites after oral administration of a corn-oil suspension relative to the Osteofix tablet.
Rohatagi S; Barrett JS; Sawyers W; Yu K; Morales RJ
Am J Ther; 1997; 4(7-8):229-38. PubMed ID: 10423615
[TBL] [Abstract][Full Text] [Related]
36. Integrated pharmacokinetic and metabolic modeling of ipriflavone and metabolites after oral administration.
Rohatagi S; Barrett JS
Am J Ther; 1997; 4(5-6):189-98. PubMed ID: 10423610
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
